Finch Therapeutics Group (FNCH) Short Interest Ratio & Short Volume → The Gold Grab of the Century (From Colonial Metals) (Ad) Free FNCH Stock Alerts $2.18 -0.05 (-2.24%) (As of 05/7/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Finch Therapeutics Group Short Interest DataCurrent Short Volume10,600 sharesPrevious Short Volume9,200 sharesChange Vs. Previous Month+15.22%Dollar Volume Sold Short$23,797.00Short Interest Ratio / Days to Cover0.2Last Record DateApril 15, 2024Outstanding Shares1,610,000 sharesFloat Size541,000 sharesShort Percent of Float1.96%Today's Trading Volume21,386 sharesAverage Trading Volume40,067 sharesToday's Volume Vs. Average53% Short Selling Finch Therapeutics Group ? Sign up to receive the latest short interest report for Finch Therapeutics Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFNCH Short Interest Over TimeFNCH Days to Cover Over TimeFNCH Percentage of Float Shorted Over Time Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySee how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.Click to read Finch Therapeutics Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202410,600 shares $23,797.00 +15.2%2.0%0.2 $2.25 3/31/20249,200 shares $23,920.92 -20.7%1.7%0.5 $2.60 3/15/202411,600 shares $29,638.00 +383.3%2.2%0.6 $2.56 2/29/20242,400 shares $6,240.00 -27.3%0.5%0.1 $2.60 2/15/20243,300 shares $8,250.00 +65.0%0.6%0.1 $2.50 1/31/20242,000 shares $5,500.00 +300.0%0.4%0.1 $2.75 Get the Latest News and Ratings for FNCH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024500 shares $1,555.00 -73.7%0.1%0 $3.11 12/31/20231,900 shares $6,859.00 -65.5%0.4%0.1 $3.61 12/15/20235,500 shares $18,920.00 -61.3%1.0%0.3 $3.44 11/30/202314,200 shares $61,060.00 -27.9%2.5%1.7 $4.30 11/15/202319,700 shares $78,997.00 -3.9%3.4%2.8 $4.01 10/31/202320,500 shares $79,540.00 -11.6%3.6%2.8 $3.88 10/15/202323,200 shares $103,936.00 -4.1%4.1%2.6 $4.48 9/30/202324,200 shares $125,356.00 -15.1%4.3%2.5 $5.18 9/15/202328,500 shares $163,590.00 +27.2%5.1%2.7 $5.74 8/31/202322,400 shares $144,704.00 +4.7%4.0%0.6 $6.46 8/15/202321,400 shares $133,964.00 +57.4%3.8%0.6 $6.26 7/31/202313,600 shares $104,176.00 -20.0%0.1%0.4 $7.66 7/15/202317,000 shares $155,890.00 -25.4%0.1%0.5 $9.17 6/30/202322,800 shares $194,484.00 -20.8%4.0%0.6 $8.53 6/15/202328,800 shares $249,120.00 -73.1%5.1%0.8 $8.65 5/31/2023106,900 shares $897,960.00 +73.5%0.6%0.4 $8.40 5/15/202361,600 shares $22,268.40 -73.3%0.4%0.2 $0.36 4/30/2023230,300 shares $92,856.96 +83.1%1.4%0.8 $0.40 4/15/2023125,800 shares $49,363.92 +47.0%0.7%0.4 $0.39 3/31/202385,600 shares $33,640.80 -9.9%0.5%0.5 $0.39 3/15/202395,000 shares $35,150.00 -51.7%0.6%0.5 $0.37 2/28/2023196,500 shares $81,351.00 +10.2%1.2%1.2 $0.41 2/15/2023178,400 shares $75,124.24 +49.8%1.1%1.1 $0.42 1/31/2023119,100 shares $59,550.00 -4.4%0.7%0.9 $0.50 1/15/2023124,600 shares $69,776.00 +22.4%0.8%1.2 $0.56 12/30/2022101,800 shares $48,864.00 +27.4%0.6%1.4 $0.48 12/15/202279,900 shares $64,711.01 +6.4%0.5%1.3 $0.81 11/30/202275,100 shares $73,605.51 -17.7%0.5%1.8 $0.98 11/15/202291,300 shares $98,439.66 -17.9%0.6%2.1 $1.08 10/31/2022111,200 shares $144,560.00 -6.1%0.7%2.5 $1.30 10/15/2022118,400 shares $188,256.00 -21.0%0.7%2.6 $1.59 9/30/2022149,900 shares $250,333.00 +19.6%1.0%3.2 $1.67 9/15/2022125,300 shares $334,551.00 -12.7%0.8%2 $2.67 8/31/2022143,600 shares $310,176.00 -37.9%1.0%2 $2.16The new financial threat that could wipe out millions… (Ad)During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.Pay close attention to this important video FNCH Short Interest - Frequently Asked Questions What is Finch Therapeutics Group's current short interest? Short interest is the volume of Finch Therapeutics Group shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 10,600 shares of FNCH short. 1.96% of Finch Therapeutics Group's shares are currently sold short. Learn More on Finch Therapeutics Group's current short interest. What is a good short interest percentage for Finch Therapeutics Group? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.96% of Finch Therapeutics Group's floating shares are currently sold short. Is Finch Therapeutics Group's short interest increasing or decreasing? Finch Therapeutics Group saw a increase in short interest in April. As of April 15th, there was short interest totaling 10,600 shares, an increase of 15.2% from the previous total of 9,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Finch Therapeutics Group's float size? Finch Therapeutics Group currently has issued a total of 1,610,000 shares. Some of Finch Therapeutics Group's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Finch Therapeutics Group currently has a public float of 541,000 shares. How does Finch Therapeutics Group's short interest compare to its competitors? 1.96% of Finch Therapeutics Group's shares are currently sold short. Here is how the short interest of companies compare to Finch Therapeutics Group: TRACON Pharmaceuticals, Inc. (1.16%), Avalon GloboCare Corp. (2.84%), Gamida Cell Ltd. (7.11%), Palisade Bio, Inc. (4.12%), Fresh Tracks Therapeutics, Inc. (0.17%), 22nd Century Group, Inc. (12.06%), Creative Medical Technology Holdings, Inc. (1.76%), Titan Pharmaceuticals, Inc. (1.72%), TC Biopharm (Holdings) Plc (35.10%), Genetic Technologies Limited (0.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Finch Therapeutics Group stock? Short selling FNCH is an investing strategy that aims to generate trading profit from Finch Therapeutics Group as its price is falling. FNCH shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Finch Therapeutics Group? A short squeeze for Finch Therapeutics Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FNCH, which in turn drives the price of the stock up even further. How often is Finch Therapeutics Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FNCH, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TCON Short Squeeze ALBT Short Squeeze GMDA Short Squeeze PALI Short Squeeze FRTX Short Squeeze XXII Short Squeeze CELZ Short Squeeze TTNP Short Squeeze TCBP Short Squeeze GENE Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FNCH) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe Gold Grab of the CenturyColonial MetalsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryGold Set to EXPLODE!Gold Safe Exchange